This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 F Albright , PH Smith , AM Richardson . Postmenopausal osteoporosis. JAMA 1941; 116: 2465–74.
3 LJ Melton , EA Chrischilles , C Cooper , AW Lane , BL Riggs . Perspective. How many women have osteoporosis? J Bone Miner Res 1992; 7: 1005–1010.
4 JA Kanis , FA Pitt . Epidemiology of osteoporosis. Bone 1992; 13 (suppl 1): 7–15.
5 O Schaadt , H Bohr . Different trends of age-related diminution of bone mineral content in the lumbar spine, femoral neck and femoral shaft in women. Calcif Tissue Int 1988; 42: 71–76.
6 BL Riggs , HW Wahner , LJ Melton , LS Richelson , HL Judd , KP Offord . Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986; 77: 1487–91.
7 A Rodin , B Murby , MA Smith Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women. Bone 1990; 11: 1–5.
8 CE Cann , HK Genant , FO Kolbo , B Ettinger . Quantitative computed tomography for prediction of vertebral fracture risk. Bone 1985; 6: 1–7.
10 PJM Elders , JC Netelenbos , P Lips , FC van Ginkel , PF van der Stelt . Accelerated vertebral bone loss in relation to the menopause: a cross-sectional study on lumbar bone density in 286 women of 46–55 years of age. Bone Miner 1988; 5: 11–19.
11 L Nilas , C Christiansen . Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 1988; 18: 529–34.
12 HK Genant , CE Cann , B Ettinger , SG Gilbert . Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982; 97: 699–705.
16 SL Hui , CW Slemenda , CC Johnston . The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1990; 1: 30–34.
17 NA Rigotti , SR Nussbaum , DB Herzog , RM Neer . Osteoporosis in women with anorexia nervosa. N Engl J Med 1984; 311: 1601–606.
18 RM Shore , RW Chesney , RB Mazess , PG Rose , GJ Bergman . Skeletal demineralisation in Turner's syndrome. Calcif Tissue Int 1982; 34: 519–22.
19 A Klibanski , SL Greenspan . Increase in bone mass after treatment of hyperprolactinaemic amenorrhoea. N Engl J Med 1986; 315: 542–46.
20 BL Drinkwater , K Nilson , CH Chestnut , WJ Bremmer , S Shainholtz , MB Southworth . Bone mineral content of amenorrhoeic and eumenorrhoeic athletes. N Engl J Med 1984; 311: 277–81.
21 WH Matta , RW Shaw , R Hesp , R Evans . Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women. Clin Endocrinol (Oxf) 1988; 29: 45–51.
23 S Murphy , K-T Khaw , JE Compston . Lack of relationship between hip and spine bone mineral density and oral contraceptive use. Eur J Clin Invest 1993; 23: 108–11.
26 C Christiansen , MS Christensen , PL McNair , C Hagen , KE Stocklund , I Transbol . Prevention of early postmenopausal bone loss: conducted 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273–79.
27 B Ettinger , HK Genant , CE Cann . Long-term oestrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985; 102: 319–24.
28 C Christiansen , BJ Riis . 17β-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990; 71: 836–41.
30 JC Gallagher , WT Kable , D Goldgar . Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 1991; 90: 171–78.
32 NS Weiss , CL Ure , JH Ballard , AR Williams , JR Daling . Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogens. N Engl J Med 1980; 303: 1195–98.
33 A Paganini-Hill , RK Ross , VR Gerkins , BE Henderson , M Arthur , TM Mack . Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981; 95: 28–31.
34 DP Kiel , DT Felson , JJ Anderson , PWF Wilson , MA Moskowitz . Hip fracture and the use of estrogens in postmenopausal women: the Framingham study. N Engl J Med 1987; 317: 1169–74.
35 T Naessen , I Persson , H-O Adami , R Bergstrom , L Bergkvist . Hormone replacement therapy and risk for first hip fracture. Ann Intern Med 1990; 113: 95–103.
36 BL Riggs , E Seeman , SF Hodgson , DR Taves , WM O'Fallon . Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 1982; 306: 446–50.
39 DT Felson , Y Zhang , MT Hannan , DP Kiel , PWF Wilson , JJ Anderson . The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993; 329: 1141–46.
41 RD Wasnich , PD Ross , LK Heilbrun , JM Vogel . Prediction of postmenopausal fracture risk with bone mineral measurements. Am J Obstet Gynecol 1985; 153: 745–51.
42 SL Hui , CW Slemenda , CC Johnston . Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988; 81: 1804–809.
43 P Gärdsell , O Johnell , B Nilsson . Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int 1989; 44: 235–42.
44 SR Cummings , DM Black , MC Nevitt Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 72–75.
45 KG Faulkner , SR Cummings , CC Glüer , L Palermo , D Black , HK Genant . Simple measurement of femoral geometry predicts hip fracture. J Bone Miner Res 1993; 8: 1211–17.
46 PD Ross , JW Davis , RS Epstein , RD Wasnich . Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919–23.
47 CW Slemenda , SL Hui , C Longcope , H Wellman , CC Johnston . Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry. Ann Intern Med 1990; 112: 96–101.
48 D Grady , SM Rubin , DB Petitti Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–37.
49 L Bergkvist , HO Adami , I Persson , R Hoover , C Schairer . The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989; 321: 293–97.
50 GA Colditz , MJ Stampfer , WC Willett , CH Hennekens , B Rosner , FE Speizer . Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990; 264: 2648–53.
51 TL Bush , E Barrett-Connor , LD Cowan Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-Up Study. Circulation 1987; 75: 1102–109.
52 E Barrett-Connor , TL Bush . Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861–67.
53 PH Wolf , JH Madans , FF Finucane , M Higgins , JC Kleinman . Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol 1991; 164: 489–94.
54 AA Nabulsi , AR Folsom , A White Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069–75.
55 M Falkeborn , I Persson , H-O Adami The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992; 99: 821–28.
56 M Falkeborn , I Persson , A Terént , H-O Adami , H Lithell , R Bergström . Hormone replacement therapy and the risk of stroke. Arch Intern Med 1993; 153: 1201–209.
57 AM Parfitt . The cellular basis of bone remodelling. The quantum concept re-examined in light of recent advances in cell biology of bone. Calcif Tissue Int 1984; 36 (suppl): S37–S45.
58 LE Lanyon . The success and failure of the adaptive response to functional load-bearing in averting vertebral fracture. Bone 1992; 13 (suppl 2): S17–S21.
59 BAA Scheven , JWM Visser , PJ Nijweide . In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 1986; 321: 79–81.
60 MA Horton , J Davies . Perspectives: adhesion receptors in bone. J Bone Miner Res 1989; 4: 803–807.
63 JE Compston , PI Croucher . Histomorphometric assessment of trabecular bone remodelling in osteoporosis. Bone Miner 1991; 14: 91–102.
64 HM Frost . Tetracycline-based histological analysis of bone remodelling. Calcif Tissue Int 1969; 3: 211–37.
65 EF Eriksen . Normal and pathological remodelling of human trabecular bone: three dimensional reconstruction of the remodelling sequence in normals and in metabolic bone disease. Endocr Rev 1986; 7: 379–408.
66 NJ Garrahan , PI Croucher , JE Compston . A computerised technique for the quantitative assessment of resorption cavities in trabecular bone. Bone 1990; 11: 241–46.
67 ME Cohen-Solal , M-S Shih , MW Lundy , AM Parfitt . A new method for measuring cancellous bone erosion depth: application to the cellular mechanisms of bone loss in postmenopausal osteoporosis. J Bone Miner Res 1991; 6:1331–38.
69 BR MacDonald , M Gowen . Cytokines and bone. Br J Rheumatol 1992; 31: 149–55.
70 JC Gallagher , D Godgar . Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 1990; 113: 649–55.
71 BP Lukert , LG Raisz . Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352–64.
72 J Reeve , PJ Meunier , JA Parsons . Anabolic effect of human parathyroid fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 1980; 280: 1340–44.
73 DJ O'Halloran , A Tsatsoulis , RW Whitehouse , SJ Holmes , JE Adams , SM Shalet . Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated growth hormone deficiency. J Clin Endocrinol Metab 1993; 76: 1344–48.
74 TJ Allain , AM McGregor . Thyroid hormones and bone. J Endocrinol 1993; 139: 9–18.
75 R Felix , MG Cecchini , H Fleisch . Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 1990; 127: 2592–94.
77 BEC Nordin , AG Need , HA Morris , M Horowitz , WG Robertson . Evidence for a renal calcium leak in postmenopausal women. J Clin Endocrinol Metab 1991; 72: 401–407.
78 JJ Stepan , J Pospichal , J Presl , V Pacovsky . Bone loss and biochemical indices of bone remodelling in surgically induced postmenopausal women. Bone 1987; 8: 279–84.
79 TJ Wronski , PL Lowry , CC Walsh , LA Ignazewski . Skeletal alterations in ovariectomised rats. Calcif Tissue Int 1985; 37: 324–28.
80 S Vedi , JE Compston , A Webb , JR Tighe . Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Relat Res 1983; 5: 69–74.
81 R Eastell , PD Delmas , SF Hodgson , EF Eriksen , KG Mann , BL Riggs . Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 1988; 67: 741–48.
84 EF Eriksen , SF Hodgson , R Eastell , SL Cedel , WM O'Fallon , BL Riggs . Cancellous bone remodelling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels. J Bone Miner Res 1990; 5: 311–19.
85 AJ Darby , PJ Meunier . Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis. Calcif Tissue Int 1981; 33: 199–204.
86 M Garcia-Carasco , MC De Vernejoul , Y Sterkers , C Morieux , D Kuntz , L Miravet . Decreased bone formation in osteoporotic patients compared to age-matched controls. Calcif Tissue Int 1989; 44: 173–75.
87 M Arlot , Edouard , PJ Meunier , RM Neer , J Reeve . Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry. Br Med J 1984; 289: 517–20.
88 T Steiniche , C Hasling , P Charles , EF Eriksen , L Mosekilde , F Melsen . A randomised study on the effects of oestrogen-gestagen or high dose oral calcium on trabecular bone remodelling in postmenopausal osteoporosis. Bone 1989; 10: 313–20.
89 EF Eriksen , DS Colvard , NJ Berg Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988; 241: 84–86.
90 BS Komm , CM Terpening , DJ Benz Estrogen binding, receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 1988; 241: 81–85.
91 R Pacifici , C Brown , E Puscheck Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991; 88: 5134–38.
92 SH Ralston , RGG Russell , M Gowen . Estrogen inhibits release of tumour necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 1990; 5: 983–88.
93 RL Jilka , G Hangoc , G Girasole Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 88–91.
94 TK Gray , S Mohan , TA Linkhart , DJ Baylink . Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell-line, UMR 106. Biochem Biophys Res Commun 1989; 158: 407–12.
95 M Ernst , JK Heath , GA Rodan . Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-1, and parathyroid hormone-stimulating adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 1989; 125: 825–33.
96 JE Compston , RWE Mellish , PI Croucher , R Newcombe , NJ Garrahan . Structural mechanisms of trabecular bone loss in man. Bone Miner 1989; 6: 339–50.
97 AM Parfitt , CHE Mathews , AR Villanueva , M Kleerekoper , B Frame , DS Rao . Relationship between surface, volume and thickness of iliac trabecular bone in ageing and in osteoporosis. J Clin Invest 1983; 72: 1396–409.
98 RWE Mellish , NJ Garrahan , JE Compston . Age-related changes in trabecular width and spacing in human iliac crest biopsies. Bone Miner 1989; 6: 331–38.
99 PI Croucher , NJ Garrahan , JE Compston . Structural mechanisms of trabecular bone loss in primary osteoporosis: specific disease mechanism or early ageing? Bone Miner 1994; 25: 111–21.
101 WS Browner , DG Seely , TM Vogt , SR Cummings . Non-trauma mortality in elderly women with low bone mineral density. Lancet 1991; 338: 355–58.
104 A Gotfredson , C Christiansen , T Palshof . The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer. Cancer 1984; 53: 853–57.
105 RR Love , RB Mazess , HS Barden Effects of tamoxifen on bone mineral density in postmenopausl women with breast cancer. N Engl J Med 1992; 326: 852–56.
106 RL Ward , G Morgan , D Dalley , PJ Kelly . Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women. Bone Miner 1993; 22: 87–94.
108 CDP Wright , RE Mansell , J-C Gazet , JE Compston . Effect of long term tamoxifen treatment on bone turnover in women with breast cancer. Br Med J 1993; 306: 429–30.
109 CDP Wright , NJ Garrahan , M Stanton , J-C Gazet , RE Mansell , JE Compston . Effect of long-term tamoxifen therapy on cancellous bone remodelling and structure in women with breast cancer. J Bone Miner Res 1994; 9: 153–59.
110 JS Johansen , BJ Riis , C Hassager , M Moen , J Jacobson , C Christiansen . The effect of a gonadotrophin-releasing hormone agonist (naferelin) on bone metabolism. J Clin Endocrinol Metab 1988; 67: 701–706.
111 MY Dawood , V Lewis , J Ramos . Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotrophin-releasing hormone agonist and danazol. Fertil Steril 1989; 52: 21–26.
112 JB Jacobson . Effects of naferelin on bone density. Am J Obstet Gynecol 1990; 162: 589–92.
113 RW Whitehouse , JE Adams , K Bancroft , CA Vaughan-Williams , M Elstein . The effects of naferelin and danazol on vertebral trabecular bone mass in patients with endometriosis. Clin Endocrinol 1990; 33: 365–73.
114 H Rico , F Arnanz , M Revilla Total and regional bone mineral content in women treated with GnRH agonists. Calcif Tissue Int 1993; 52: 354–57.
116 BJ Riis , C Christiansen , JS Johansen , J Jacobson . Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists. J Clin Endocrinol Metab 1990; 70: 920–24.
117 JM Eldred , PJ Haynes , EJ Thomas . A randomised double-blind controlled trial of the effects on bone metabolism of the combination of naferelin acetate and norethisterone. Clin Endocrinol (Oxf) 1992; 37: 354–59.
118 ES Surrey , HL Judd . Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotrophin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomised trial. J Clin Endocrinol Metab 1992; 75: 558–63.
119 R Lindsay , DM Hart , A Kraszewski . Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J 1980; 280: 1207–209.